cancer-stem-cells

Documents about cancer-stem-cells

• Analysis Of The Effects Of Microrna-130a Suppression On The Proliferation And Characteristics Of Cancer Stem Cells In The Human Colorectal Cancer Cell Lines#290300USM Repository
• Cardiopulmonary Fitness and Its Clinical Determinants of a Population of Childhood Cancer Survivor#889960ClinicalTrials.gov
• Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)#844967ClinicalTrials.gov
• In Vitro Models of Liver and Pancreatic Cancer#855871ClinicalTrials.gov
• Visceral and subcutaneous adipose stem cells modulate colorectal cancer cell progression: direct and indirect contact distinctly accelerate tumor aggressiveness.#148381NCBI PubMed Central
• Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells#888237ClinicalTrials.gov
• The epithelial-mesenchymal transition factor SNAIL paradoxically enhances reprogramming#954761Koc University Digital Collections
• Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells#683965eScholarship
• An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast Cancer#804016ClinicalTrials.gov
• Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant#968687ClinicalTrials.gov
• Plerixafor Harvesting And No Chemotherapy for Transplantation of Autologous STem Cells In Cancer (PHANTASTIC)#831921ClinicalTrials.gov
• Development, characterization and evaluation of 5-fluorouracil loaded gold nanoparticles conjugated with cd133 antibody targeting positive-survivin colorectal cancer stem cells#373029USM Repository
• Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation#910024ClinicalTrials.gov
• Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling.#647223REPOSITORIO INSTITUCIONAL DA UFOP
• Evaluation of the Impact of Sports-inspired Onco-coaching on Health-related Quality's Life of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells#843588ClinicalTrials.gov
• Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas#835229ClinicalTrials.gov
• CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation#675856eScholarship
• Neuropilin-1: A key protein to consider in the progression of pediatric brain tumors#301032HAL (France)
• Mechanoresponsive stem cells to target cancer metastases through biophysical cues#492103eScholarship
• Crizotinib Resistance Mediated by Autophagy Is Higher in the Stem-Like Cell Subset in ALK-Positive Anaplastic Large Cell Lymphoma, and This Effect Is MYC-Dependent#137331HAL (France)
• Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System#1046912ClinicalTrials.gov
• The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies#903443ClinicalTrials.gov
• Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer.#480979NCBI PubMed Central
• The Collection and Storage of Umbilical Cord Blood for Transplantation#868787ClinicalTrials.gov
• Prognostic significance of NLRP-3 expression in solid cancers: a systematic review and meta-analysis#676295Europe PMC
• Imetelstat as Maintenance Therapy After Initial Induction Chemotherapy in Non-small Cell Lung Cancer (NSCLC)#906478ClinicalTrials.gov
• The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation#620076eScholarship
• Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer#908456ClinicalTrials.gov
• Recombinant human collagen XVII protects epidermal stem cells from blue light-induced photoaging by downregulating the Notch pathway#374106Figshare
• Ultrasensitive proteomic quantitation of cellular signaling by digitized nanoparticle-protein counting#934992Koc University Digital Collections
• Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood#889881ClinicalTrials.gov
• Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma#314327ClinicalTrials.gov
• Additional file 2 of Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer#478450Figshare
• Additional file 1 of Mesenchymal stem cell-induced metabolic reprogramming of EGFR-wild-type tumor cells drives therapeutic resistance in EGFR-mutant non-small cell lung cancer#478451Figshare
• Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines#848265ClinicalTrials.gov
• Hypoxia-preconditioned dental pulp stem cells alleviate acetaminophen-induced liver failure via promoting MYC-HIF1A/HIF-1α-BNIP3-mediated mitophagy#342053Figshare
• Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer#852972ClinicalTrials.gov
• Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation#800296ClinicalTrials.gov
• Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia#909912ClinicalTrials.gov
• CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies#858972ClinicalTrials.gov
• Transcriptomic analysis reveals that BMP4 sensitizes glioblastoma tumor-initiating cells to mechanical cues#620125eScholarship
• HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies#911752ClinicalTrials.gov
• Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant#407722ClinicalTrials.gov
• CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma#230391ClinicalTrials.gov
• Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma#181754ClinicalTrials.gov
• Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease#873866ClinicalTrials.gov
• Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)#806979ClinicalTrials.gov
• HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection#879866ClinicalTrials.gov
• Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies#992687ClinicalTrials.gov
• Contemporary dialogues in health sciences#928238Repositório Institucional da UFMG